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Summary
The quest to discover the variety of ecological niches
inhabited by Saccharomyces cerevisiae has led to
research in areas as diverse as wineries, oak trees
and insect guts. The discovery of fungal communities
in the human gastrointestinal tract suggested the
host’s gut as a potential reservoir for yeast adaptation.
Here, we report the existence of yeast populations
associated with the human gut (HG) that differ from
those isolated from other human body sites. Phyloge-
netic analysis on 12 microsatellite loci and 1715 com-
bined CDSs from whole-genome sequencing revealed
three subclusters of HG strains with further evidence
of clonal colonization within the host’s gut. The pres-
ence of such subclusters was supported by other
genomic features, such as copy number variation,
absence/introgressions of CDSs and relative polymor-
phism frequency. Functional analysis of CDSs specific
of the different subclusters suggested possible alter-
ations in cell wall composition and sporulation fea-
tures. The phenotypic analysis combined with
immunological profiling of these strains further
showed that sporulation was related with strain-
specific genomic characteristics in the immune recog-
nition pattern. We conclude that both genetic and envi-
ronmental factors involved in cell wall remodelling
and sporulation are the main drivers of adaptation in
S. cerevisiae populations in the human gut.
Introduction
Despite in-depth knowledge of the genetic, molecular
and phenotypic traits regulating the physiology of Sac-
charomyces cerevisiae, the forces shaping its origin and
evolution are still debated. The long lasting association of
S. cerevisiae with human activities (3150 BC) (Cavalieri
et al., 2003; Fay and Benavides, 2005; Legras et al.,
2007; Goddard et al., 2010; Liti, 2015) has led to the idea
that its wide use in fermentation has caused its domesti-
cation. Few studies have examined the population biol-
ogy of S. cerevisiae, its genetic variation and evolution
(Fay and Benavides, 2005; Aa et al., 2006; Ezov et al.,
2006; Ruderfer et al., 2006; Legras et al., 2007; Zhu
et al., 2016; Almeida et al., 2017; Zhu et al., 2017). How-
ever, whole genome analysis classified S. cerevisiae
strains accordingly to the isolation source (Oak, Wine/
European or West African) and the type of human activity
from which they derived (Dunn et al., 2012), suggesting
that the population structure of this yeast consists of a
few isolated lineages and mosaicism (Liti et al., 2009; Liti,
2015). Despite the available reports on the worldwide dis-
tribution and genetic diversity of S. cerevisiae (Peter
et al., 2018), it is still unclear how and to what extent
human intervention has shaped the baker’s yeast popula-
tion structure (Liti et al., 2009; Schacherer et al., 2009;
Goddard et al., 2010; Borneman et al., 2011). Recent
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discovery of the role of wasps’ gut as a winter reservoir
and potential evolutionary niche for S. cerevisiae indi-
cated how the ecological cycle of this microorganism is
just beginning to be understood (Stefanini et al., 2012).
The possible evolution of S. cerevisiae in the gastrointes-
tinal tract of the animals is not limited to wasps or fruit
flies (Knight et al., 2015), but probably extends to verte-
brates and finally to mammals. Since yeasts are ubiqui-
tous in human-related environments, especially in
association with food production (leavening bread and
fermenting wine and beer), it is not surprising that yeasts,
including S. cerevisiae, populate the skin (Findley et al.,
2013), mucosal membranes (Sobel et al., 1993; Liguori
et al., 2016), breast milk (Boix-Amorós et al., 2017),
blood (Smith et al., 2002; Swinne et al., 2009) and respi-
ratory (Tawfik et al., 1989; Williams et al., 2007) and
intestinal tracts (Ott et al., 2008; Liguori et al., 2016;
Sokol et al., 2017) of humans (Rizzetto et al., 2014).
Exposure to fungi is constant, and recent studies have
highlighted that the mycobiota is a significant player in
host–microbe interactions, being also able to shape both
innate and adaptive immunity (Hardison and Brown,
2012; Sancho and Reis e Sousa, 2012; Nguyen et al.,
2015; Romani et al., 2015; Strati et al., 2016a). Candida
albicans is the best-known human commensal, but
S. cerevisiae has also been shown to be a potential colo-
nizer of the human intestinal tract (Xu et al., 1999; Ange-
bault et al., 2013; Strati et al., 2016a). A recent
hypothesis is that human environment-associated
S. cerevisiae strains gave rise to clinical S. cerevisiae
causing colonization/infection (Strope et al., 2015).
Noticeably, this species was identified in both immuno-
compromised patients (Muñoz et al., 2005.; Williams
et al., 2007; Swinne et al., 2009) and healthy subjects
(Sobel et al., 1993; Smith et al., 2002).
Currently, the fungal community is emerging as a
player of the symbiotic interactions in the gut ecosystem
(Ott et al., 2008; Liguori et al., 2016; Sokol et al., 2017).
Studies investigating fungal communities in chronic
inflammation, especially in Inflammatory Bowel Diseases
(IBD), described a more heterogeneous mycobiota in
patients affected by Crohn’s Disease (CD) compared to
healthy subjects, suggesting a role for altered mycobiota
as the causative agents of inflammatory diseases and
‘leaky gut’ syndrome (Ott et al., 2008; Schulze and Son-
nenborn, 2009; Li et al., 2013; Sokol et al., 2017). An
association between gut inflammation and abundance of
different yeast species, including S. cerevisiae, was
found in mouse models of chemically induced colitis (Iliev
et al., 2012; Chiaro et al., 2017). Furthermore, Ott and
colleagues showed an enrichment in S. cerevisiae strains
in IBD faecal samples (Ott et al., 2008). A study on pae-
diatric subjects reported a clear fungal dysbiosis in CD
patients with an enrichment in Candida spp. and a
reduction of S. cerevisiae in disease versus remission,
thus proposing a positive role of S. cerevisiae coloniza-
tion (Sokol et al., 2017). On the other hand, Liguori et al.,
(2016) observed that S. cerevisiae was enriched in the
gut mucosa of CD patients, but this yeast species was
also present in noninflamed gut mucosa. Strikingly, one
of the markers proposed to discriminate CD from Ulcera-
tive Colitis (both IBDs) is CD positivity for anti-Saccharo-
myces cerevisiae antibodies (ASCA) (McKenzie et al.,
1990; Quinton et al., 1998; Sendid, 1998). All these stud-
ies have highlighted the relevance of S. cerevisiae in the
intestinal homeostasis and inflammation, but the contro-
versial results made difficult to have a definitive answer
on its role in the host health and disease. The wide
genetic and phenotypic variability observed for this yeast
and the different human-associated and environmental
sources could be the causes behind the inability to draw
general conclusions on the role of yeast in contributing to
or protecting from disease (Rizzetto et al., 2016).
Thus, three general questions should be resolved:
(i) are there differences in terms of abundance of strains
between patients and healthy subjects? (ii) are
S. cerevisiae strains found in the human gut genotypi-
cally and phenotypically different from nonhuman envi-
ronments? (iii) how related are S. cerevisiae gut strains
compared to those found on other human body sites and
originated by environment or human activities? (iv) are
there genetic features characterizing gut strains?
In the current work, we investigated the genetic and
phenotypic characteristics, variability and population
structure of S. cerevisiae isolates from the human gut of
paediatric patients. In addition, to contextualize the impli-
cations of genetic variation on the ability of strains to sur-
vive and evolve in the harsh intestinal environment, we
characterized the strains for traits potentially related to
survival or adaptation to the gut environment and we
investigated the impact of the observed genetic variations
on the immunogenicity of these strains.
Results
Strain isolation, identification and typing
Aiming at the isolation of S. cerevisiae strains from human
faeces, we plated faecal aliquots onto selective media
(YPD supplemented with chloramphenicol, see Experimen-
tal procedures) allowing the growth of only yeasts and
fungi. To avoid mating of isolates after plating, faecal ali-
quots were diluted to have around ten isolates per plate.
Faecal samples were collected from 34 paediatric Crohn’s
Disease (CD) patients, 27 Ulcerative Colitis (UC) patients,
1 non-IBD paediatric patient and 32 healthy children (HC).
To identify the isolates’ species, we analysed the
ITS1-5.8S-ITS2 region using Sanger sequencing and
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assigned the species by comparing the results with all the
ITS1-5.8S-ITS2 sequences available in the NCBI database.
If the best match was a S. cerevisiae strain, the isolate was
identified as S. cerevisiae. Using this procedure, we identi-
fied a total of 35 S. cerevisiae isolates, the great majority of
which was found in CD patients, with 27 isolates from six dif-
ferent CD patients (17.7% of CD patients), one isolate from
1 UC (3.7%), five isolates from one non-IBD paediatric
patient (nIBD) and two isolates from HC (3.1%; see Table 1
for isolate origin and nomenclature). However, we could not
find any associations among the isolation of S. cerevisiae
strains and the type of donor, neither comparing healthy
donors against patients nor considering the different pathol-
ogies (Chi-squared test of independence p = 0.523).
In order to investigate the origin of the isolated strains,
we performed phylogenetic analysis based on 12 microsat-
ellite loci (Legras et al., 2007) (Fig. 1A). Neighbour-Joining
clustering based on chord distances (Takezaki and Nei,
1996) was used to assess the similarity among gut iso-
lates and other strains from a wide variety of sources (soil,
insect gut, grape, wine fermentation, bakery and clinical
environment), for a total of 286 strains (Legras et al.,
2007). The inclusion of strains isolated from wasp intes-
tines was aimed at evaluating genetic similarities among
strains isolated from the gastrointestinal tract.
Strain clustering was performed through K-means anal-
ysis on chord distances, with the best number of clusters
(n = 16) being identified as the smallest minimizing the
distances among co-clustering strains (Supporting Infor-
mation Fig. 1). Strains isolated from human faeces
grouped in three clusters, with just three exceptions (the
strains YB7, YB8 and YG12). A significant fraction of gut
isolates (16 out of 35), grouped in a cluster (which we
called the Human Gut 1, HG1 cluster) together with five
laboratory strains S288C, FY10, W303, fl100 and fl200
(Fig. 1A, beige shading). This cluster encompasses iso-
lates (YB, YD and YE series) obtained from three CD
patients (B, D and E respectively, Table 1). We identified
two other subclusters of HG strains (indicated in blue in
Fig. 1A). One group (including 1 strain from an UC
patient, 2 strains from CD patients and 2 strains from
HC), which we called HG2 (Fig. 1A, pink shading) clus-
tered closely to strains used in bread-making (Capa1,
YS4 and MUCL42920, isolated from bread and beer).
Another group of four HG strains (called HG3, blue shad-
ing in Fig. 1A), isolated from a single CD patient
(YH1-YH4), co-clustered with the SK1 laboratory strain.
Interestingly, in two human subclusters we also found
strains that had previously been isolated from the guts of
wasp caught in the same geographical area where all
patients and healthy subjects resided (Tuscany, Italy;
Fig. 1A). An additional cluster included the strains iso-
lated from the ‘B’ patient, YB7 and YB8, that clustered
with strains isolated from wine fermentation and grapes
collected from the Tuscany (Italy) region where that
patients resided (Fig. 1A). Wasp intestines were previ-
ously shown to bear S. cerevisiae strains representing a
large part of the local genetic diversity of this species
(Stefanini et al., 2012), and the clustering based on
microsatellite data confirms this observation, as wasp
strains spread along the tree (Fig. 1A). Some strains iso-
lated from wasp intestines were similar to the gut iso-
lates, probably because of the similarity of isolation
sources (both are from intestines) and geographical loca-
tion (faecal donors lived in the same region where the
wasps were caught, Tuscany, Italy).
Noteworthy, the strains isolated from the same patient
resulted more genetically similar than other strains
Table 1. Isolated human gut strains.
Donor class Donor ID Strain label
Crohn’s Disease (CD)
no. subjects = 34,
having S. cerevisiae = 6
A YA5* [2*]
B YB7*, YB8*, YB9, YB10*, YB11, YB12,
YB13
P YP1, YP2, YP3, YP4 [1*]
D YD1*, YD2, YD3, YD4, YD5, YD6
E YE1*, YE2*, YE3*, YE4, YE5
H YH1* [3*], YH2, YH3, YH4
Ulcerative Colitis (UC)
no. subjects = 27,
having S. cerevisiae = 1
UC22 YUC22* [1*]
non-IBD Disease (nIBD)
no. subjects = 1
having S. cerevisiae = 1
G YG9, YG12, YG13, YG14, YG15
Healthy Children (HC)
no. subjects = 32,
having S. cerevisiae = 2
N19 YN19
EU13 Y13EU*
For CD (Crohn’s Disease), UC (Ulcerative Colitis), nIBD (non-IBD Disease) and HC (Healthy Children) donor classes we reported the total num-
ber of donors and the number of S. cerevisiae strains isolated in the corresponding class. Strains marked with an asterisk (*) have been sub-
jected to genome sequencing. Values in squared brackets indicate the number of sequenced meiotic segregants.
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belonging to the same cluster (i.e., among strains of the
YB, YD, YE and YH series), as indicated by their co-
clustering (Fig. 1A) and by the comparison of distances
among strains isolated from the same faecal sample and
co-clustering strains (Fig. 1B). In fact, strains isolated
from the same individual are more similar among each
other than strains belonging to the same cluster (Mann–
Whitney U test fdr < 0.05, Fig. 1C). To further support the
observation that the distance among strains isolated from
the same donor was lower than the distance among
strains from other sources, we compared the genetic
distances among strains isolated from the same donor
and among strains randomly selected from the dataset of
strains characterized by microsatellite analysis (10 000
sampling iterations for each group of strains isolated from
the same donor). In more than 85% of the permutations,
the strains isolated from the same donor were more simi-
lar among each other compared to re-sampled datasets
(Supporting Information Fig. 2). These results suggested
either a clonal expansion of strains in the human intestine
or multiple colonisations of a given faecal donor from
multiple strains of the same source population.
Fig. 1. Human gut Saccharomyces
cerevisiae strain typing. S. cerevisiae
strains isolated from faecal samples
and identified by means of ITS1-5.8S-
ITS2 sequencing were typed by char-
acterizing 12 microsatellite loci.
A. Neighbour-joining clustering based
on the DC-chord distances calculated
on the strains’ microsatellite profiles.
Shaded rectangles highlight the clus-
ters identified through K-means anal-
ysis. Italic numbers indicate the
cluster numbering reported in panel
b; on the right, the main clusters
including strains isolated from human
faeces; grey numbers reported in cor-
respondence of the nodes of these
subclusters are the confidence values
of the corresponding node according
to bootstrap analysis. B. Comparison
of chord distances, calculated from
microsatellite profiles, among strains
isolated from the same patient (B, D,
E, G, H, P) or among strains cluster-
ing with the human faeces isolates.
HG1, HG2, HG3, 8 and 13 refer to
the clusters highlighted in panel
a. Each grey circle represents the dis-
tance between two strains of the
given group (either cluster or faecal
donor). C. Results of statistical tests
carried out to evaluate the differences
in distances among strains grouped
according to either donor or cluster-
ing. Mann–Whitney U test was carried
out among interstrain distances, the
resulting p-values were corrected for
multiple testing (false discovery rate).
Differences were considered signifi-
cant when fdr < 0.05.
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Strains sequencing, phylogenomics and population
analysis
To search for genetic traits characterizing HG strains, we
obtained the entire genome sequence of a selection of
18 isolates from human gut, together with a set of four
wasps gut strains, five strains from grapes and one strain
from wines collected in the Florence area, Italy; Support-
ing Information Table 1). Sequenced strains were
selected to represent the broadest genetic variability
observed in the microsatellite analysis (Fig. 1A), by
including one strain per major group and strains that did
not cluster in any major group. As a quality control of our
study, we sequenced a clone of S288c progenitor, the
EM93 strain, isolated from decomposing fig (Mortimer
and Johnston, 1986). In order to disclose the genomic
features shared by intestinal isolates, strains from wasp
intestines were selected among those that were closer to
human gut isolates according to the microsatellite data
clustering (Fig. 1A). In fact, by sampling a wider genetic
variability of wasp strains, we would have also included
strains simply vectored by wasps (Stefanini et al., 2012)
and hence not showing features peculiar of intestinal iso-
lates. For phylogenomic comparison purposes, we
included in our analysis several strains isolated in previ-
ous studies from various geographical locations and iso-
lation sources, also encompassing a large number of
isolates from clinical specimens (Liti et al., 2009; Strope
et al., 2015). Considering that such external reference
strains were sequenced as haploids, to properly perform
a phylogenetic comparison among strains, we sequenced
meiotic segregants of candidate strains from this study
that were able to sporulate and give viable spores. Other
analyses (e.g., copy number variation, CDSs loss, new
CDSs) were carried out on both meiotic segregants and
parental (polyploid) strains.
The percentage identity of reads mapped on the S288c
strain genome reference ranged between 93% and 97%
(Supporting Information Table 2). SNP calling at high
coverage (lowest = 46.7, strain YP4-40D; highest = 304.7,
strain YH1-28C) of newly sequenced strains with respect
to the reference genome revealed a wide variability of
SNPs/indels (Single Nucleotide Polymorphisms/inser-
tions deletions), from a minimum of 538 total SNP/indels
in the YE1 strain to a maximum of 101 330 in the YUC22
strain (Supporting Information Table 2).
SNP calling using the S288c laboratory strain’s
genome as a reference was used to reconstruct coding
sequences of strains and perform per-CDS reverse multi-
ple sequence alignment in order to obtain a robust (see
Experimental procedures) genome-wide alignment
encompassing 1715 CDSs from 144 strains, for a total of
245 990 informative loci (see Experimental procedures
for further details). In order to fully exploit this information,
we have created a publicly accessible database (http://
bioserver2.sbsc.unifi.it/bioinfo/yeastpop/index.html) to
inspect alignments and produce phylogenetic trees
based on concatenations of desired CDSs among the
1715 available CDSs.
Phylogenetic analysis by approximately maximum-
likelihood tree construction confirmed the similarity
among groups of strains isolated from human faeces
observed with microsatellite analysis (Fig. 2A). STRUC-
TURE analysis on genetic variants (Fig. 2B) assigned
strains isolated from human faeces to single clusters,
indicating a common ancestor with co-clustering strains
(Liti et al., 2009; Strope et al., 2015). The only exception
was the YA5 strain meiotic segregant (YA5-46A), which
could not be assigned to a specific cluster and was
hence identified as a mosaic strain, as described in
Experimental Procedures (Fig. 2A and B). Ancestry anal-
ysis performed on genome-wide data after removal of
strain-specific loci (keeping loci with minor allele fre-
quency > 0.05 in the set of strains) identified seven popu-
lations that were defined as HG1, HG2, HG3, HB
(Human Body), WC (Wild Clade), sake and Lab
(Laboratory; Fig. 2B). The HG1, HG2 and HG3 clusters
were named according to the clustering also observed by
means of microsatellite analysis (Fig. 1A). Three of our
identified clusters did not include strains isolated from
human faeces: HB (‘Human Body’, i.e., strains isolated
from various nongut sites of the human body), WC (‘Wild
Cluster’, i.e., strains isolated from wild environments and
natural fermentations) and the previously identified (Liti
et al., 2009) sake cluster (strains used for sake fermenta-
tion; see Fig. 2). The strains isolated from donors E, B
and D were inferred to descend from the HG1 ancestor,
previously identified as Wine European (WE) (Liti et al.,
2009). As observed with microsatellite data, the strain
Y13EU and the meiotic segregants of the strains YUC22,
YP4 and YA5 (YUC22-34C, YP4-40D and YA5-46D
respectively) clustered together with the wasp intestine
strains YVPC7.6 and BIBVC5.3 descending from the
same HG2 ancestor (Fig. 2A and B). The meiotic segre-
gants of the YH1 strain (YH1-28A, YH1-28B and
YH1-28C), clustering with the wasp intestine strain
BIBVC1.1 and strains isolated from samples collected in
West Africa (from bakery, wine and other fermentations),
were inferred to descend from the HG3 ancestor, previ-
ously identified as WA (West African) (Liti et al., 2009).
Interestingly, all the strains isolated from clinical samples
collected from patients in Italian hospitals (YJM969,
YJM975, YJM978, YJM981, YJM984, YJM987, YJM990,
YJM993, YJM996 by Strope et al., 2015) grouped in the
HG1 cluster, together with some of the strains isolated
from human faeces in this study (YB7, YB8, YB10, YD1,
YE2 and YE3, Supporting Information Table 1 and in pink
in Fig. 2A). On the contrary, the remaining clinical strains,
isolated from hospital located in other countries (Portugal,
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United Kingdom-Newcastle, Romania, California, District
of Columbia, Michigan, North Carolina, Texas-USA), clus-
tered separately from either human faeces or wasp intes-
tine isolates (pink labels in Fig. 2A).
Genome-wide investigations on gut strains
To further describe the genome settings of human gut
strains, we performed several genome-wide analyses
(Fig. 3) aimed at identifying acquisitions with respect to the
reference genome S288c (introgressed CDSs, Supporting
Information Table 3), chromosomal aberrations (through
analysis of coverage, Supporting Information Fig. 3 and
Supporting Information Table 4), lost/multiplied (see the defi-
nition below) coding DNA sequences (CDSs) defined by
CDS-based copy number variations (CNVs, Supporting
Information Table 5), and defective CDSs – whose coding
sequence showed the insertion of a premature stop codon
or to an out-of-frame indel (Supporting Information Table 6).
In order to discover genes present in newly sequenced
strains and missing in the reference strain (referred to as
‘introgressed’), for each strain, we assembled the reads
that did not map to the S288c genome. The total 2447
identified CDSs were translated and searched in the
NCBI nonredundant protein database with BLAST
(Supporting Information Table 3). In order to avoid inflat-
ing the relevance of introgressions, we evaluated
whether introgressed CDSs could complement (‘recover’)
lost or defective CDSs (found with the procedure
described below) in each strain separately. Recovered
CDSs were excluded from the list of introgressed CDSs.
Similarly, in the following sections on lost and defective
CDSs we refer to lists of CDSs not including recovered
genes. A total of 298 CDS-derived proteins proved to
confidently derive from previously known proteins (12.1%
of 2455 total newly assembled CDSs). Among these,
233 were derived from other S. cerevisiae strains, 30 in
other Saccharomyces spp. and 15 in Candida spp.
(Supporting Information Table 3). Interestingly, some
genes derived from other Saccharomyces spp. belonged
to families such as FLO (flocculation), HXT (hexose trans-
porters), PAU (seripauperin), ENA (sodium-pumping
Fig. 2. Reconstruction of S. cerevisiae
population phylogeny. A. S. cerevisiae
strain cluster based on the
concatenated alignments of 1715 infor-
mative CDSs (245 990 loci), obtained
from whole genome sequences. Col-
our code of labels indicates the strains
origin. Shaded areas indicate the
inferred ancestry, as shown in panel b.
B. The strains’ most probable ancestry
inferred by fastStructure analysis per-
formed on whole-genome SNPs
selected as having minor allele fre-
quency > 0.05 (28 473 loci). The pro-
portions of the most probable inferred
ancestors for each strain are indicated
by the colours of vertical bars, as
reported in the legend. The blue aster-
isk indicates the YA5-46A strain, iso-
lated from human faeces and inferred
to be a mosaic strain. Naming of clus-
ters: sake – sake ancestor; WA –
West Africa (as reported by Liti et al.,
2009); HG – Human Gut; Lab – labo-
ratory strains; WC – wild cluster; HB –
Human Body; WE – Wine European.
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ATPase), THI (thiamine synthesis), IMA (isomaltase),
PHO (cell surface glycoprotein involved in phosphate
metabolism; Supporting Information Table 3). The clus-
tering of strains based on presence/absence of new
genes partially reproduced the clustering observed on
whole-genome data (Fig. 3A), the only exception being
YUC22-34C, YB7 and YB8 strains that clustered sepa-
rated from previously co-clustering strains. To investigate
whether the presence of new genes could cause gain of
functions, we searched for enrichments in specific GO
terms (Supporting Information Table 3). The results
showed that the HG2 group was enriched for carbohy-
drate metabolic process, cation-transporting ATPase
activity, hydrolase activity and flocculation (CDSs from
the FLO family; Supporting Information Table 3).
Interestingly, the new CDSs characteristics of the HG1
cluster were enriched in GO terms related to flocculation.
In addition, the HG1 group was enriched for NADH dehy-
drogenase (ubiquinone) activity and respiratory chain
(Supporting Information Table 3).
Coverage analysis carried out on entire chromosomes
revealed a few cases of chromosomal polyploidies,
namely on chromosome I in the YB7, YB8 and YP4-40D
strains, on chromosome IX in the Y13EU, BIBVC5.3 and
YVPC7.6 strains, and on chromosome II and the terminal
portion of chromosome XI in the YUC22 strain
(Supporting Information Fig. 3 and Supporting Informa-
tion Table 4). It is surprising to observe that the coverage
of the above mentioned chromosomes, despite higher, is
not above the classic 2x threshold with respect to the rest
Fig. 3. CNVs, gene loss prediction, discovery of new genes and polymorphism frequencies of strains belonging to different clusters/ancestors.
Clustering of sequenced strains based on: A) gained genes, B) CNV’s, C) defective genes and D) polymorphism frequencies. The colour of the
strain name indicates the strain’s environmental origin, while the branch colour indicates the cluster in which the strain was found, as reported in
Fig. 1 (both colour scheme are shown in key). E. Survey of copy number variations (CNVs) and defective genes occurring along the chromo-
somes. Strains were grouped according to the clustering membership observed by means of ancestry analysis on genomic data. For each chro-
mosome, two plots were generated: the upper reporting the average value of CNVs in CDSs, calculated in 5000 bp windows for strains in the
corresponding group; the lower reporting the average number of defective CDSs calculated in 5000 bp windows in the corresponding group.
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of the genome. Although this finding could be explained
for diploid strains (e.g., YB7, YB8, Y13EU, BIBVC5.3,
YVPC7.6 and YUC22), where the given chromosome
could be present in three copies and the other chromo-
somes in two copies, such behaviour in the haploid strain
YP4-40D remains elusive. Aiming at the identification of
genetic variants associated with and possibly causing the
observed polyploidies, we explored the sequences of
genes known to be involved in chromosomal segregation,
as defined by the Gene Ontology classification. We could
not find any genetic variation specific for the strains bear-
ing a polyploid chromosome I (Supporting Information
Table 4). Contrarily, variants in the BIR1 (Ser825Pro),
CDC45 (Phe362Asn, Gly366Asp and Gln496Asn), CHL1
(Asp264Asn and Thr449A), CHL4 (Asp264Asn and
Thr449Ala), CSM1 (Met178Leu), DSN1 (Ala133Glu,
Asp377Ala, Ser413Cys and Leu477Stop), IPL1
(Phe65Cys and Ile140Met), MCM7 (Thr371Ile), NDC10
(Leu150Thr, Val179Lys, Pro472Tyr, Asp549Gln), PLC1
(Trp178Cys and Pro774Ser), RFC4 (Asp86Gly), SHP1
(Glu67Gly), SPC105 (Val827Leu) and SPT6 (Ser6Leu)
genes were specifically associated with a polyploidy in
chromosome II (Supporting Information Table 4). Similarly,
the polyploidy in chromosome IX was associated with vari-
ants in the NDC10 (Arg666Asp and Arg666Glu) and
SGO1 (Ala577Gly and Ala577Arg) genes (Supporting
Information Table 4). However, it has to be considered that
such results may be affected by the limited amount of ana-
lysed strains (e.g., only one strain, YUC22, showed a poly-
ploidy of chromosome II). Strikingly, the polyploidies
observed in chromosomes I and IX for strains isolated from
human faeces (Supporting Information Table 4) were previ-
ously found to characterize S. cerevisiae strains used in
Italian industries (Zhu et al., 2016).
For each CDS, CNV was calculated as the
log2-transformed ratio of the number of reads mapping
against the CDS divided by the median coverage of the
genome. Notably, the clustering based on the CNV profiles
of sequenced strains (Fig. 3B) generally reproduced the
clustering observed through whole-genome sequence
comparison (Fig. 2), with strains being grouped according
to their ancestry, even if strains belonging to the HG1 clus-
ter were further subdivided into subclusters mainly corre-
sponding to their source of isolation (Fig. 3B). In order to
gain functional insights on CNVs, we defined two catego-
ries for each CDS: ‘lost’ CDSs, with median coverage at
least twice lower than the median coverage of the whole
genome (CNV < −1) and not found among CDSs identified
from nonmapping reads (see Supporting Information Fig. 4
for a graphical representation) and ‘multiplied’ CDSs, with
median coverage at least twice higher than the median
coverage of the whole genome (CNV > +1, possibly indi-
cating over-representation compared to the reference
strain). A detailed report of this analysis is described in
Supporting Information Table 5. The strains belonging to
the HG1 cluster showed the highest number of cluster-
specific CNVs, with 47 multiplied CDSs (7 of which were
Ty elements) and 74 lost CDSs (10 of which were Ty ele-
ments). The strains belonging to the HG3 cluster showed
only two cluster-specific multiplied CDSs and 44 lost CDSs
(5 of which were Ty elements). Functional enrichment anal-
ysis on the lists of multiplied or lost CDSs specific for either
HG clusters or intestinal/nonintestinal strains revealed that
HG2 and intestinal strains bore a higher copy number of
CDSs related to the catabolism of nitrogen sources
(e.g., allantoin), as reported in Table 2 and Supporting
Information Table 5. Interestingly, CDSs multiplied in nonin-
testinal strains were functionally associated with GO terms
related to the plasma membrane, while CDSs lost in intesti-
nal strains were functionally associated with GO terms
related to the cell wall (Table 2 and Supporting Information
Table 5). Concerning transposable elements, we found a
large variability among the CNVs of all the classes of Ty
(Ty1, Ty2, Ty3 and Ty4) when comparing strains belonging
to the LAB, HG1, HG2 and HG3 clusters, with the sole sig-
nificant association of lost Ty3 CDSs in intestinal compared
to nonintestinal strains (Supporting Information Fig. 5).
We further analysed CDSs having an out-of-frame
indel or whose resulting protein after translation contains
a premature stop codon (to which we will refer as ‘defec-
tive CDSs’), identifying a total of 414 CDSs defective in
at least one of the sequenced strains (Supporting Infor-
mation Table 6). A few defective CDSs were found to be
replaced by CDSs identified from nonmapping reads and
therefore were excluded from further analyses. The clus-
tering of strains’ profiles based on the presence of defec-
tive CDSs reproduced the clustering observed through
phylogenetic analysis on whole-genome polymorphisms
(Fig. 2), grouping strains according to their ancestry
(Fig. 3C). The location of defective CDSs for each strain
in every chromosome is reported in Supporting Informa-
tion Fig. 6. Similarly to what we did for CDS CNVs, we
examined the defective CDSs characteristic of the HG
groups by an enrichment analysis on Gene Ontology
(GO) terms (using YeastMine tools, fdr < 0.05; Support-
ing Information Table 6). HG1 and the sequenced strains
sharing the HG1 (WE) ancestor were characterized by
the highest number of cluster-specific defective CDSs
(94 CDSs, Supporting Information Table 6), enriched in
the cell periphery GO term (Table 2). Among the 41 CDSs
defective specifically in the members of the HG2 cluster,
we found an oligopeptide transporter (OPT1) and a non-
catalytic subunit for phospholipid translocase (CRF1)
(Supporting Information Table 6). Finally, exploring the
52 defective CDSs characterizing the HG3 cluster, we
found 41 CDSs defective in all these strains of which
7 were related to the cell membrane or wall (BSC1,
ECM12, FIT2, FIT3, HVG1, MNN5 and SUR7) and 2 were
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related to cations transportation (CCC2 and MMT2).
Interestingly, intestinal strains contained 258 defective
CDSs, which were nondefective in strains from other
sources and enriched in gene ontologies related to metal
homeostasis (Table 2). On the other hand, the 37 CDSs
defective in nonintestinal strains only did not show any
enrichment in gene ontology terms.
Furthermore, we measured the relative frequency of
polymorphism in CDSs of sequenced strains and the
resulting matrix (Supporting Information Fig. 7) was used
in a cluster analysis (Fig. 3D). We found a substantial
agreement between the isolates clustering based on fre-
quency of polymorphism (Fig. 3D) and whole-genome
phylogenetic comparison (Fig. 2).
Phenotyping of gut strains
Considering the relevant genetic features varying
between gut strains and among strains isolated from fae-
cal samples and from other sources, we asked whether
Table 2. GO terms enrichment analyses.
Gene ontology
Type
Cluster /
group biological process Cellular component Molecular function
CNV higher
than 1
HG1 none integral component of plasma
membrane [GO:0005887],
intrinsic component of plasma
membrane [GO:0031226], cell
periphery [GO:0071944],
plasma membrane part
[GO:0044459],plasma
membrane [GO:0005886]
inorganic molecular entity
transmembrane transporter
activity [GO:0015318], ion
transmembrane transporter
activity [GO:0015075],
transmembrane transporter
activity [GO:0022857]
HG2 allantoin metabolic process
[GO:0000255], allantoin
catabolic process
[GO:0000256], cellular
amide catabolic process
[GO:0043605]
none none
HG3 none none none
intestinal allantoin metabolic process
[GO:0000255], allantoin
catabolic process
[GO:0000256]
none none
nonintestinal none cell periphery [GO:0071944],
integral component of plasma
membrane [GO:0005887],
intrinsic component of plasma
membrane [GO:0031226],
plasma membrane
[GO:0005886], plasma
membrane part [GO:0044459]
none
CNV lower
than −1
(lost)
HG1 none none none
HG2 none none none
HG3 none none none
intestinal none cell wall [GO:0005618], external
encapsulating structure
[GO:0030312], fungal-type cell
wall [GO:0009277], cell
periphery [GO:0071944],
vacuole [GO:0005773]
structural constituent of
cell wall [GO:0005199]
nonintestinal none none none
Defective
genes
HG1 none cell periphery [GO:0071944] none
HG2 none none none
HG3 none none none
intestinal iron ion homeostasis
[GO:0055072], metal ion
homeostasis [GO:0055065],
cellular iron ion homeostasis
[GO:0006879]
none none
nonintestinal none none none
Results of the GO Enrichment analysis performed on multiplied, lost or defective CDS lists specific of the different clusters/groups investigated in
this work. For each GO category, only terms enriched with an fdr < 0.05 are included.
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these differences were reflected at the phenotypic level.
Hence, we studied gut strains for differences in traits
relevant for growth and survival in the gut environment:
invasiveness, resistance to several physiological tem-
peratures and pH, and sporulation (McCusker et al.,
1994; Diezmann and Dietrich, 2009) (Fig. 4 and Sup-
porting Information Table 7). Additionally, we evaluated
whether the identified populations subtended pheno-
typic differences in the S. cerevisiae isolates (Fig. 4
and Supporting Information Table 7). The YH strains,
belonging to HG3 cluster, were the only human intes-
tine strains able to form pseudohyphae and resist to
oxidative stress and showed the highest sporulation
rate (>30% asci/cell at 37 C; Fig. 4 and Supporting
Information Table 7). HG1 strains (especially YD, YE
and some YB) were unable to invade the medium and
sporulate (Fig. 4 and Supporting Information Table 7).
While all the tested strains showed the same ability to
grow at various pH values, a wider variability was
observed in the growth ability at various temperatures
among the tested strains (Fig. 4). We found that the
growth abilities at 4 C, 40 C, 42 C and 44 C were
dependent on the intestinal origin of the strains, with
strains isolated from intestines (either human or insect)
having a slightly increased fitness at 4 C (Chi-squared
test p = 0.022) and a decreased fitness at 40 C (Chi-
squared test p < 0.001), 42 C (Chi-squared test
p < 0.001) and 44 C (Chi-squared test p < 0.001) com-
pared to strains isolated from other sources (Fig. 4). Fur-
thermore, intestinal strains (isolated from either human
faeces or insect intestines) showed a significantly lower
sporulation efficiency at 28 C and 37 C than strains iso-
lated from other sources (Mann–Whitney U test
p < 0.001, Supporting Information Fig. 8). On the other
hand, a few traits statistically differed between human
and wasp intestinal strains: human gut isolates showed a
higher fitness at 40 C (Chi-squared test p < 0.001) and
at 42 C (Chi-squared test p = 0.001) than wasp iso-
lates (Fig. 4).
Interestingly, the gut strains’ sporulation efficiency mir-
rored the microsatellite-based clustering and whole-
genome-based ancestral lineages (Figs 1A and 2).
Indeed, the HG1 group, deriving from the HG1
(WE) ancestor showed low sporulation rate (0% or rang-
ing from 10% to 15%), the HG2 group showed medium/
low sporulation rate and HG3 strains [with HG3
(WA) ancestry] showed the highest percentage of sporu-
lation (> 30%; Supporting Information Table 7). The
sequence variation of the RME1 gene, a negative regula-
tor of sporulation, has been shown to correlate with the
strains’ sporulation efficiency (Gerke et al., 2009). In par-
ticular, the insertion of an adenine in position −308
(upstream to the gene’s codon start) was found to be
associated with an increase in the strain sporulation effi-
ciency (Deutschbauer and Davis, 2005). We confirmed
the relations between the adenine insertion and the spor-
ulation efficiency for our strains (Supporting Information
Fig. 9). In addition, according to our results, the clustering
of RME1 sequences (also including an upstream region
encompassing the previously identified relevant locus,
Supporting Information Fig. 9) reproduced the clustering
obtained with microsatellite analysis (Fig. 1A), and
depicted the same strain grouping identified by means of
ancestry analysis (Fig. 2).
Since genome sequencing indicated a genetic variation
in cell wall and mannose genes as well as sugar metabo-
lism genes in HG strains, we analysed the cell wall sugar
composition (see Experimental procedures) of a selection
of 18 strains isolated from human faeces or other
Fig. 4. Strains phenotyping. Strains isolated from various environ-
ments were characterized in traits relevant for growth and survival in
the gut environment: invasiveness, sporulation efficiency, resistance
to several physiological temperatures and pH. Traits were quantified
by Z-score, calculated as described in Experimental Procedures.
Strain labels are coloured according to the isolation source
(environment).
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sources. HPLC analyses revealed that HG strains’ cell
wall shows a significantly lower content of mannose com-
pared to laboratory and grape strains, a lower content of
glucose compared to grape strains (Mann–Whitney
U test, fdr < 0.05, Fig. 5A) and a higher content of galac-
tose compared to grape strains (fdr < 0.01; Fig. 5A). In
addition, strains isolated from human faeces show a
higher content of glucosamine in their cell walls com-
pared to strains isolated from all the other tested sources
(grapes, laboratory and insect intestines; fdr < 0.05;
Fig. 5A). Furthermore, HG1 strains showed a higher
mannose content in their wall compared to strains deriv-
ing from the laboratory ancestor (fdr < 0.05), and signifi-
cantly lower amounts of galactose compared to strains
deriving from both HG2 and laboratory ancestors
(Fig. 5B, fdr < 0.05).
Immunophenotyping of S. cerevisiae isolates
As observed through analyses carried out on whole-
genome sequences and confirmed by cell wall composi-
tion analysis, human gut strains show a characteristic cell
wall composition. Considering that the sugar moieties of
cell wall are the principal antigens sensed by the host
immune system during host-fungal interaction (Perez-
García et al., 2011; Lewis et al., 2012; O’Meara et al.,
2015), we evaluated whether the observed differences in
cell wall composition and the genomic traits were
mirrored by the strains’ immunogenicity. Direct contact of
immune cells with fungi leads to activation of antigen pre-
senting cells and subsequent priming of adequate pro-
inflammatory T helper (Th) response or regulatory T cells
(Treg) response (Romani, 2011). Previous studies
showed a fungal strain-dependent variation of immune
recognition and consequent immune reactivity depending
on strain features (Marakalala et al., 2013; Rizzetto et al.,
2013; Smith et al., 2014; Cavalieri et al., 2018). Hence, to
characterize the immune response elicited by human gut
S. cerevisiae isolates, peripheral blood mononuclear
cells (PBMCs) were challenged with HG isolates. Strains
isolated from grapes (Sgu52 and Sgu421), natural envi-
ronments (BB1533 and BT2240) and a laboratory strain
(SK1), were used as controls. The induced cytokine pro-
files were determined by using the Human Milliplex®
assay (Merck-Millipore) (Supporting Information Fig. 10
and Fig. 6A–C). We measured the pro-inflammatory cyto-
kines IL-6, IL-1β and TNF-α, expressed by antigen pre-
senting cells in response to fungal antigens (Qin et al.,
2016; van de Veerdonk et al., 2017), as well as the Th
response cytokines IFN-γ (Th1) and IL-17 (Th17), both
known to allow resistance towards colonization of fungi
such as Aspergillus fumigatus (van de Veerdonk et al.,
2017) and Candida albicans (Gaffen et al., 2011;
Gozalbo et al., 2014) and the Th2 cytokine IL-13,
involved in allergic response (Gagliani and Huber, 2017).
We also measured the level of IL-10, an anti-
Fig. 5. Cell wall sugar components of S. cerevisiae strains.Galactose, glucosamine, glucose and mannose amounts (%) detected in the cell wall
of strains grown in presence of glucose (YPD) as carbon sources. The analysed strains are categorized considering (A) the different origins (envi-
ronment), as indicated in figure, and (B) the inferred ancestors (Cluster). The graphs provide the p-values obtained by Mann–Whitney U test, cor-
rected for multiple testing with the false discovery rate approach; * = fdr < 0.05.
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inflammatory cytokine involved in immune tolerance
towards fungi (Roussey et al., 2016). The in vitro assay
showed strain-specific differences in the cytokine profiles
triggered by the challenge (Supporting Information
Fig. 10 and Fig. 6A–C) and revealed the Th-polarizing
cytokines IL-17A, IFN-γ and IL-10 as the main factors dis-
criminating HG strains induced- immune responses
(Fig. 6 and Supporting Information Fig. 10). The variable
cytokine profiles induced by the environmental strains
and human faeces isolates indicates strain-specific rather
than source specific immune responses (Fig. 6D and
Supporting Information Fig. 4). The Principal Component
Analysis carried out on quantified IL-17A, IFN-γ and IL-
10, and on strain sporulation levels reproduced the same
strain grouping (Fig. 6D) previously observed by compar-
ing the strains’ whole-genome sequences (Fig. 2).
Nonsporulating HG1 strains (i.e., YE1, YB10, YD1)
showed a tendency towards the induction of IFN-
γ-mediated responses. HG2 strains with low sporulation
efficiency (i.e., YA5, YB7, YP4 and YUC22) induced high
IL-17A production (Fig. 6D). The opposite trend was
observed for the high sporulator YH1 and SK1 strains,
derived from the HG3 (WA) cluster, in which the high
IFN-γ mediated-inflammatory response was counterba-
lanced by high levels of the immunosuppressive cytokine
IL-10 (Fig. 6D).
Discussion
In this work, we performed genome-scale and phenotypic
analyses aimed at exploring the possible features of
Fig. 6. Immunophenotyping of S. cerevisiae strains. A–C. quantified amounts of IL-10, IL-17 and IFN-γ produced by PBMCs upon stimulation with
S. cerevisiae cells; PBMCs isolated from healthy donors were challenged with S. cerevisiae strains isolated from human faeces, grapes, other
natural sources and laboratory strains for 5 days and cytokines (IFN-γ, IL-10 and IL-17A) released in the supernatants were quantified. Bars in
plots represent the mean  standard deviation (error bars) of cytokine amounts from six healthy PBMCs donors; us: unstimulated cells. D. Corre-
lation among genotyping, immunophenotyping and sporulation ability of HG S. cerevisiae strains. Correspondence analysis, carried out by using
the S. cerevisiae strains as cases and T-polarizing cytokine levels produced by healthy human PBMCs in response to the strains (quantitative
variables) and the categorized sporulation rates (high > 25%, low < 25%) as variables. Pie charts indicate the ancestor lineage proportion of each
whole-genome sequenced strain (as reported in Cluster legend and coloured as in Fig. 2), grey points represent strains with no genomic data.
Ancestries were calculated for isolates or for meiotic segregants. If meiotic segregants deriving from the same parental strain showed different
ancestries, a pie-chart was plotted for each segregant (e.g., YA5 derivatives), otherwise a single representative pie-chart was plotted (e.g., YH1
derivatives). Strains not characterized by genome sequencing but tested for immunophenotyping, were indicated with grey dots. In grey shadows,
visual representation of strain grouping inferred using PAM analysis on PCA coordinates.
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S. cerevisiae enabling its survival and possible inhabit in
the human gut, therefore, candidating it to enter the list of
the much better documented natural (e.g., grape, soil,
trees) or artificial (e.g., fermentation) yeast environments.
It is known that a few fungal species, mostly Candida
spp., are able of growing and colonizing the gastrointesti-
nal tract. On the other hand, strains from species consid-
ered like ‘passengers’, rather than colonizers, such as
S. cerevisiae, have been shown to impact gut ecology
(Hallen-Adams and Suhr, 2017), and Ott and colleagues
reported an enrichment in IBD patients’ faecal samples of
S. cerevisiae as well as other fungal species (Ott et al.,
2008). Although obtained in a limited number of donors
and isolated strains, we found that S. cerevisiae is more
abundant in CD patients than healthy controls. Microsat-
ellite analysis revealed that gut strains show genetic simi-
larities with foodborne strains (HG1 and HG2 clusters),
but also with strains isolated from other sources collected
in distant geographical locations, such as West Africa
(HG3 cluster). The hypothesis that some of the human
intestine strains are foodborne is also supported by the
analysis of chromosome poly-ploidies. In fact, poly-
ploidies in chromosomes I and IX were found to charac-
terize Italian industrial strains (Zhu et al., 2016), and were
also found in the present study in some of the human
intestine isolates descending from the HG1 and HG2
ancestors.
Notably, strains isolated from the same donor were
more similar among each other than strains sharing the
same genetic cluster or randomly sampled from the strain
dataset. These indications suggest that either the strains
isolated from faeces of the same patient arose from
clonal expansion within the gut or that patients were colo-
nized by clonal strains from the same source. Either way,
the observed residence of S. cerevisiae clonal popula-
tions only in patient intestines may indicate that a gut
microbial alteration (dysbiosis) occurring in chronic
inflammation could admit the expansion or the survival of
strains showing particular characteristics (Koh, 2013).
Indeed, increase of the intestinal permeability, dysbiosis
or even impairment of the immune system are all condi-
tions previously documented as complicating the fungal-
host interplay (Underhill and Iliev, 2014; Chiaro et al.,
2017). The comparison of human gut isolates with strains
isolated from wasp intestines revealed further insights on
this topic. Wasp intestines isolates were previously
shown to represent the regional genetic and phenotypic
variability of S. cerevisiae (Stefanini et al., 2012; Dap-
porto et al., 2016). In the current study, we report that
some wasp intestine isolates cluster together with human
gut isolates, indicating either that humans are exposed to
(and colonized by) a limited portion of the regional
S. cerevisiae strains or that only a few strains are able to
persist/survive in the human intestine. It is intriguing to
observe that among all clinical strains isolated in other
studies, only those isolated from patients in Italian hospi-
tals (Liti et al., 2009; Strope et al., 2015) clustered
together with a few strains isolated from human faeces
(in the cluster HG1), suggesting that environmental and
foodborne strains from the same geographical region can
be the source to select clinically associated yeasts, in
individuals predisposed to be colonized by them. Con-
versely, human gut isolates also encompassed strains
belonging to other clusters, partially reproducing what
previously observed for wasp strains (Stefanini et al.,
2012). Nevertheless, wasp strains encompass a wider
genetic variability than human gut strains, again suggest-
ing that the latter may be subjected to selection (Stefanini
et al., 2012). Prompted by the observations on microsat-
ellite data, we searched for genetic characteristics even-
tually characterizing gut strains by means of whole-
genome sequencing. CNV analysis revealed shared
peculiarities for strains isolated from human and insect
guts, compared to strains isolated from other sources
(grapes and wine). In particular, intestinal strains showed
a higher number of copies of CDSs involved in allantoin
metabolism, and a lower number of copies of CDSs
related to the vacuole function and to the cell wall com-
pared to nongut strains. The modulation of such function,
possibly caused by the modification of CDS numbers,
may result in a physiological advantage for strains in the
intestinal environment. In fact, high allantoin levels have
been reported in the body fluids of IBD patients, resulting
from the general inflammation status associated with the
disease (Schicho et al., 2012). Differently, the complete
profile of either lost or new CDSs did not differentiate the
strains according to the isolation source, but helped in
further understanding the genetic differences among
strains isolated from faecal samples.
Considering the relevant genetic features varying
among intestinal strains and between strains isolated
from faecal samples and from other sources, we won-
dered whether these differences were reflected at the
phenotypic level. The characterization of strains isolated
from intestines for phenotypes putatively relevant for
microbial survival in the human gut revealed that strain
sporulation efficiency and sequence variation in a specific
sporulation-associated allele of RME1 (Gerke et al.,
2009) mirrored the strains grouping observed by compar-
ing the whole-genome sequences of intestinal strains,
mostly for the HG3 cluster composed by highly sporulat-
ing strains. This result suggests a connection between
sporulation and ability of certain strains to survive in the
human (inflamed/dysbiotic) gut. Furthermore, wasp and
human intestine isolates share an increased fitness at
4 C, while most of them have a reduced growth rate at
40 C, 42 C and 44 C and a generally lower sporulation
efficiency at 28 C and 37 C (absent in HG1 cluster)
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compared to strains isolated from other sources. These
traits specific for several intestinal strains may suggest
that S. cerevisiae is allowed to reside and grow within
the intestine, provided that it maintains slow growth and
low sporulation rates. We may hypothesize these strains
characterized by a moderate division and sporulation
rates may have higher chances to persist/survive within
the human intestine, in particular in presence of the com-
plex inflammatory environment such as that observed in
CD patients (Brand, 2009). Healthy human immune cells
have been shown to mount a Th1 inflammatory response
– counterbalanced by a Treg response – against
S. cerevisiae cells through the recognition of cell wall
mannans (Rizzetto et al., 2010). Conversely, lack of
exposed mannans led to the induction of a Th17 inflam-
matory response to spores, enriched in chitin, a molecule
exposed in S. cerevisiae bud scars and in spore cell wall
(Rizzetto et al., 2010). It is interesting that previous meta-
genomics studies in CD patients (Liguori et al., 2016)
showed that an enrichment in S. cerevisiae is associated
with decrease of Candida and with remission. Thus, we
could speculate that S. cerevisiae populations colonizing
the gut use the host’s immune system to fight potential
competitors, and that this reduction in opportunistic path-
ogens (such as Candida) is benign in pathological condi-
tions, such as CD.
Probably even more strikingly, human intestine isolates
showed a peculiar composition of their cell wall, bearing
in particular a higher content of galactose and glucos-
amine compared to the strains isolated from all the other
sources. The cell wall enrichment in galactose residues
has been associated to filamentous growth, cell–cell
adhesion, flocculation in S. pombe (Tanaka et al., 1999)
and biofilm production in C. albicans (Cavalieri et al.,
2018), favouring invasiveness, further indicating that gut
colonization requires specific traits. Thus, the peculiar
cell wall composition of these strains appears to be a
gut-specific feature and could represent a selective
advantage to survive and expand in the host gut. Further
and more specialized studies are necessary to evaluate
the role of galactose in the strains persistence in the gut.
Concerning the strains’ immunogenicity, only strains
having high sporulation efficiency or belonging to the
HG3 cluster induce a concordant immune response, trig-
gering a mixed response (the high level of pro-
inflammatory IFN-γ-mediated-Th1 response was counter-
balanced by strong IL-10 induction) potentially enabling
yeasts to escape immune-surveillance. On the contrary,
the other two classes of human gut strains (nonsporulat-
ing and low-sporulating or belonging to HG1 and HG2
clusters) triggered elusive and apparently incoherent
immune responses. Overall, the observations highlight a
remarkable correlation between yeast isolates’ specific
genetic make-up and immunogenicity, suggesting
alternative but convergent strategies for the colonization
of the gut environment.
Despite the results reported here should be validated
in larger cohort of faecal donors and yeast isolates, the
findings indicate how, from an evolutionary perspective,
the gut environment could serve as a reservoir and evo-
lutionary niche for S. cerevisiae, in which genetic makeup
could ultimately influence its immunogenicity, highlighting
the need to consider the interplay between fungal cell
wall and gut immune function in determining yeast popu-
lation selection. Our observations highlight three condi-
tions correlating with a S. cerevisiae strain ability to
survive and persist in the human intestine: (i) the ability
to exploit the harsh environment, by metabolizing allan-
toin, present at high levels in IBD patients due to the
action of inflammation-associated high radical oxygen
species on uric acid (Schicho et al., 2012); (ii) a cell wall
enriched in mannose, possibly allowing their persistence
in the pre-existent Th1-based inflammatory environment
of CD patients’ intestines through IL-10 production
(Brand, 2009); and (iii) a moderate sporulation efficiency
and growth rate at temperatures characterizing inflamed
intestines, avoiding the induction of a Th17-driven inflam-
matory immune response able to kill/eradicate yeast cells
(Reuter et al., 2007; Rizzetto et al., 2010).
In intestines characterized by an inflammatory condi-
tion, as we observed in CD patients, the residence of
strains with peculiar genetic characteristics and cell wall
composition could be the result of selection and adapta-
tion to a peculiar gut environment. In this perspective,
S. cerevisiae is generally recognized as safe (GRAS),
since its ability to induce trained immunity provides the
host with benefits such as improved immunity and resis-
tance to pathogens. This could lead us to reconsider the
definition of ‘domestication’ of S. cerevisiae, emphasizing
that humans, wasps and possibly all food-associated
insects or other animals, could have vectored
S. cerevisiae among fermented food and beverages.
Studying the evolution of the strategies used by yeast to
evade immune surveillance or to provide a selective
advantage to the host by modulating immune responses
could lead to discovery the genetic features potentially
turning a friend into a foe. In this novel perspective, the
combination of genotyping, phenotyping and immunophe-
notyping approaches described in this article is a power-
ful approach to describe S. cerevisiae diversity.
Experimental procedures
Strain isolation, identification and typing
A total of 93 paediatric subjects were enrolled at the
Meyer Children’s Hospital (Florence, Italy). All parents or
caregivers of paediatric faecal donors (healthy or IBD
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patients) were made aware of the nature of the experi-
ment, and gave written informed consent for faecal sam-
ple collection, in accordance with the sampling protocol
approved by the Ethical Committees of the Meyer Chil-
dren’s Hospital and the Azienda Ospedaliera Universi-
taria Careggi, Florence, Italy (Ref. n. 87/10). All
individuals were Caucasian and their age ranged from
4 to 19 years. Faeces were collected from all paediatric
subjects by physicians and caregivers who had been
instructed to collect faecal samples under sterile condi-
tions to avoid contamination. A 1 ml faeces aliquot was
plated onto YPD agar medium (1% yeast extract, 2%
peptone, 2% D-glucose, 2% agar) supplemented with
chloramphenicol (1 mg/ml) to avoid bacterial growth, and
incubated for 2–3 days at 28 C. Yeast genomic DNA
was extracted as previously described (Hoffman and
Winston, 1987). Strains were identified by sequencing
the ITS1-5.8S-ITS2 region, using the ITS1 and ITS4
primers as previously described (Supporting Information
Table 2) (Sebastiani et al., 2002). Saccharomyces cere-
visiae strains were identified by ITS1-5.8S-ITS2 region
sequence homology with the S. cerevisiae ITS1-5.8S-
ITS2 region sequences available in the NCBI database.
The strains identified as S. cerevisiae were used in fol-
lowing analyses and compared to strains isolated from
different sources. For strain typing, a set of 286 strains
isolated from various sources (Supporting Information
Table 1) was characterized in terms of allelic variation at
12 microsatellite loci (Legras et al., 2007). The 12 micro-
satellite loci were amplified as previously described and
using the primers listed in Supporting Information
Table 7. The PCR amplicon sizes of the 12 loci were
assessed by capillary electrophoresis. The chord dis-
tance Dc matrix was calculated for each strain with a
laboratory-made program. The phylogenetic tree was
obtained with the Neighbour-joining method from the dis-
tance matrices with the Phylip Neighbour 3.67 package
and drawn up using MEGA4.0 (Tamura, 2011). The tree
was rooted using the midpoint method. Strain clustering
was investigated by means of K-means analysis on chord
distances, with the best number of clusters being identi-
fied as the lowest number of clusters minimizing the dis-
tances among strains of the same cluster. Significant
differences among distances between strains grouped
according to faecal donor or clustering were evaluated by
means of Mann–Whitney U test as previously done
(Novitsky et al., 1999; Gilbert et al., 2001). In addition,
distances among strains isolated from the same donor
were compared with distances among an equal number
of strains randomly sampled from the set of strains char-
acterized by means of microsatellite analysis. Strains
from healthy subjects (Y13EU and YN19) and from
patient A (YA5) were not included in the comparison
because a single strain was isolated from the
corresponding faecal donor. 10 000 sampling iterations
were carried out for each comparison, for a total of
60 000 comparisons (10 000 iterations × 6 groups of
strains isolated from the same faecal donor). p-Values
were corrected for multiple testing (false discovery rate,
fdr), and differences were considered significant if
fdr < 0.05.
Genome sequencing, reads alignment and genotype
calling
For whole genome sequencing purposes, strains were
selected to maximize the genomic variety inferred from
microsatellite phylogeny. Strains whose genome were
sequenced in this study are listed in Supporting Informa-
tion Table 1. Whole genome sequencing was performed
using the Genome Analyser IIx (GAIIx) platform and
HiSeq2000 sequencing instruments. The standard Illu-
mina protocol with minor modifications was followed for
the creation of short-insert paired-end libraries (Illumina
Inc., Cat. # PE-930-1001), as reported in Cavalieri and
colleagues (2018).
Illumina run generated 16 504 557  7 966 339.6 qual-
ity paired end sequences, with a read length average of
113.8  21.4 base pairs (excluding the primer
sequences). On average, we found ~16.5 million filtered
reads and 14.9 million mapped reads. Illumina reads
were subjected to quality control (filtering and trimming)
using NGS QC Toolkit v2.3.3 (Patel and Jain, 2012).
Paired reads were filtered with parameters −l 70, (cutOf-
fReadLen4HQ) and −s 20 (cutOffQualScore), allowing
the elimination of reads with a PHRED quality score
lower than 20 for more than 30% of their lengths. More-
over, reads were trimmed at the 30 end for bases with a
PHRED quality score lower than 30. Paired reads were
mapped to the reference genome (Saccharomyces cere-
visiae S288c, NCBI ID = 559292) using Burrows-Wheeler
Aligner (BWA 0.7.12) (Li and Durbin, 2009).
The Genome Analysis Toolkit (GATK 2.1) was used for
base quality score recalibration, Indel (insertion or dele-
tion) realignment, duplicate removal and to perform SNP
and Indel discovery (McKenna et al., 2010), resulting in
strain-specific vcf files. The coding sequences of the
investigated S. cerevisiae strains were generated using
variant imposition (a.k.a. consensus calling) in order to
create uniform sets of genes for further analysis. Briefly,
this technique inserted variants (SNPs and Indels) pro-
duced by GATK and specific for each strain into the cod-
ing sequences of the reference strain (Supporting
Information Table 2) to create accurate CDSs useful for
phylogenetic comparison across strains. Other isolates
previously published and used in the comparison (listed
in Supporting Information Table 1) were (1) identified in
the NCBI Assembly database and their CDSs (“CDS from
© 2018 Society for Applied Microbiology and John Wiley & Sons Ltd., Environmental Microbiology, 21, 50–71
64 M. Ramazzotti et al.
genomic” file type) downloaded from GenBank using
NCBI Download Assembly tool (strains genomes pub-
lished by Strope and collaborators (Strope et al., 2015))
or (2) Sanger Institute FTP repository (cere_assemblies.
tgz) for strains published by Liti and collaborators (Liti
et al., 2009). Other strains available in NCBI Assembly
were evaluated for their degree of CDS annotation and
judged not suitable for inclusion. However, we consid-
ered this set of strains sufficiently broad, in terms of num-
ber of strains, and considering their environmental
isolation sources and genetic variability, to allow an
exhaustive comparison of S. cerevisiae populations. As a
whole, the dataset of genomic sequences encompassed
29 newly sequenced strains and 119 strains previously
described: 38 from clinical samples (collected from vari-
ous parts of the human body, usually in presence of co-
occurring infections) and 81 from various sources; such
strains were sequenced in previous studies: 37 from the
Liti and colleagues study (2009), 82 from the Strope and
colleagues study (2015).
For ortholog identification, fasta headers of sequences
were parsed using the ‘gene=’ tag as an annotation key.
CDSs described as unknown or not-annotated, absent
from the reference strain S288C or pertaining to mito-
chondrial or plasmid DNA were excluded from further
analyses. All the sequencing data generated for this
study are publically available both as raw and processed
whole-genome sequences (ENA ID: ERP002541 and
Array Express ID: E-SYBR-8).
Phylogenomic analysis of CDS
The coding sequences of genes present in the genomes
of the previously described 144 selected S. cerevisiae
strains (see the “Genome sequencing, reads alignment
and genotype calling” paragraph) were collected in gene-
specific sequence files in order to produce a coherent
collection of orthologs. The resulting 2297 ortholog sets
were individually processed by reverse multiple
sequence alignment (rMSA). Briefly, CDSs were trans-
lated, aligned with clustal-omega (Sievers and Higgins,
2014) and then codons were juxtaposed in coding
sequences using protein alignment as a guide. This
allowed the creation of CDS-based ortholog specific
MSAs, that were eventually reduced in size (giving a
‘reduced MSA’) by removing conserved alignment col-
umns. In order to avoid inflating differences among
strains due to aberrant alignments (usually due to frame-
shifting indels in at least one strain, leading to a gap rich
alignment) all orthologs whose reduced MSA was longer
than 50% or the initial MSA, were considered unreliably
aligned and excluded from further analyses. This proce-
dure allowed us to evaluate whether CDSs with poten-
tially confounding alignments were truly polymorphic or
aberrant. In fact, while polymorphic genes are relevant to
disclose species evolution, as they produce correct align-
ments and maintain bona fide a role in selective pres-
sure, aberrant mutations may not be informative because
producing inconsistent alignments and reasonably
ignored by selective pressure due to a loss-of-function of
the defective gene.
The remaining reduced ortholog MSAs were
concatenated to build a single CDS-derived ‘genome-
wide’ alignment, as previously described (Ramazzotti
et al., 2012) involving 144 strains and encompassing
1715 genes, for a total of 245 990 informative loci. This
alignment was eventually used to produce a phyloge-
nomic tree using FastTree 2.1.10 SSE3 (Price et al.,
2010) with default parameters and for population struc-
ture analysis.
Population structure analysis
For investigations of population structure, the previously
described CDS-derived ‘genome-wide’ alignment was
analysed by using fastStructure to assign individual
strains to populations (Raj et al., 2014). Aiming at the
identification of the best number of populations (K) in our
dataset, we first binned SNPs by minor allele frequency
(maf, only loci with maf > 0.05 were used for this analy-
sis), then fastStructure analysis was carried out testing
from 3 to 13 K values (Raj et al., 2014). The best K was
identified by using the chooseK.py script of the fastStruc-
ture software (Raj et al., 2014). Finally, strains were
assigned to a given population if showing at least 60%
ancestry from that population. Strains assigned to the
same cluster are supposed to descend from the same
ancestor. Strains with less than 60% ancestry from any
of the other populations were considered mosaics.
Despite strains not assigned to a given cluster are com-
monly considered mosaics (e.g., Liti et al., 2009; Knight
et al., 2015), we acknowledge that they could potentially
belong to cluster currently not represented among the
S. cerevisiae strains included in our dataset.
Identification and analysis of S288C introgressions
In order to discover the CDSs present in newly
sequenced strains and missing in the reference strain
S288C (previously termed as introgressions), the pool of
Illumina reads failing to align onto the reference strain
genome was assembled using ABySS 1.9.0 (Simpson
et al., 2009), adjusting the k-mer value so that contigs
with the highest N50 were maximized. The AUGUSTUS
2.5.5 gene finder (Stanke et al., 2008) was then run on
the resulting assembled contigs using the default Sac-
charomyces cerevisiae gene model. The identified CDSs
were translated and searched with Protein–Protein
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BLAST 2.2.31+ against the Nonredundant RefSeq pro-
tein dataset. NCBI BLAST was used to annotate CDSs,
considering the best hit as that presenting the highest
value of the ranking score S = alignment length/protein
length * identity %, therefore favouring hits that spanned
the whole query protein. In order to avoid inflating the rel-
evance of introgressed CDSs, we further evaluated
whether introgressed genes could complement (‘recover’)
lost or defective CDSs in each strain separately. Briefly,
the original S288c CDSs deemed as lost or defective in a
specific strain were searched (BLAST) against the pool
of introgressed CDSs from this strain, filtering hits using
the score described above. Introgressions with a
score > 90 for a lost or defective CDS were considered
‘recovery’ events, with the effect of removing recovered
CDSs from the matrices of defective and lost CDSs
described in next sections. Truly introgressed CDSs
(i.e., those not recovering original genes) were eventually
collected and further analysed as a presence/absence
binary matrix (Supporting Information Table 3) involving
all strains. Complete hierarchical clustering on the binary
matrix was performed using the hclust function of the R
statistical package on a Jaccard’s Index-based distance
matrix from the R package Vegan (Dixon, 2003). For the
functional enrichment analysis of introgressed gene lists
selected on the basis of strain clustering NCBI IDs were
converted in UniProt codes, then a Fisher Exact Test
was performed against a reference pan-genome
(obtained by combining S288C proteins and all the intro-
gressed proteins, and GO-annotated by EBI quickGO),
with p-values adjusted for multiple comparisons using
Benjamini–Hochberg correction Benjamini and Hochberg
(1995). Significantly enriched Gene Ontology terms were
identified as having p-value<0.05.
Coverage analysis and CDS-copy number estimation
Starting from bam files created by BWA and optimized
with GATK (see above), the samtools software (mpileup
command) was used to extract the coverage value for all
reference positions in the different strains. For each strain
analysed, the median coverage of the entire genome
M as well as the median coverage of specific CDSs
m (coordinates were extracted from the corresponding gff
annotation file) was computed. The value CNV = log2(m/
M) was calculated for each CDS, representing the copy
number variation (CNV), that is, the excess or defect in
coverage with respect to the sequenced genome. This
allowed direct comparison of CNV within the entire set of
newly sequenced genomes. In the text, we refer to genes
having CNV lower than −1 as ‘lost’ (i.e., their CDS
median coverage is at least twice lower than that of the
rest of the genome). Recovered CDSs (see details in par-
agraph “Identification and analysis of S288C
introgressions”) were removed from the lists of lost
CDSs. CDSs were identified as cluster- or source-
specific if their CNV was lower than −1 or higher than
1 in at least a strain of the given group and not in any
strain of the other groups (Supporting Information
Table S3). To graphically summarize the distribution of
CNVs along the chromosomes (and generate Fig. 3A),
the average CNV values, not including TY elements nor
subtelomeric CDSs, along each chromosome in nonover-
lapping bins sized 5000 bp were calculated for strains
grouped according to their clustering. Functional enrich-
ment (i.e., Gene Ontology enrichment on molecular func-
tion) was carried out with YeastMine (Balakrishnan et al.,
2012) on lists of CDSs grouped according to either strain
clusters or isolation sources; enrichment significance was
tested by means of hypergeometric test and corrected
through Holm–Bonferroni approach, with significantly
enriched Gene Ontology terms identified as having p-
value< 0.05. Complete hierarchical clustering on the
binary matrix encompassing the CNVs for all genes and
all strains was performed using the hclust function of the
R statistical package on a Jaccard’s Index-based dis-
tance matrix from the R package Vegan (Dixon, 2003).
To evaluate the presence of chromosomal aneu-
ploidies we used, for each chromosome, the CNV for-
mula specified above on nonoverlapping genome
stretches of 5000 bp, irrespective on the presence of
CDSs. Statistically supported polyploid chromosomes
were identified by applying the same approach adopted
by Zhu and colleagues (2016). Briefly, for each strain we
calculated the difference of the median coverages
between every couple of chromosomes. The significance
of this difference was evaluated by applying a Mann–
Whitney U-test between the median coverages, calcu-
lated in 5000 bp bins, of the two compared chromo-
somes. The p-values were then corrected for multiple
testing (fdr). If the absolute value of the difference of
coverage between two chromosomes was higher than
the 35% of one of the two compared chromosomes,
and the comparison had an fdr < 0.05, the two chromo-
somes were considered as having different ploidies.
Once identified the strains showing consistent aneu-
ploidies (e.g., a given chromosome had a coverage sig-
nificantly differing from the large majority of the
chromosomes of the same strain), we searched for
associations between aneuploidies and genetic varia-
tions in genes known to be associated with chromo-
somal segregation. Aiming at this, we obtained the list
of genes annotated as belonging to the Gene Ontology
‘chromosomal segregation’ (SGD) and identified the
genetic variants for each strain. Then, we grouped
strains as presenting polyploidies or having specific
polyploid chromosome and we searched for genetic
variants specific for each strain group.
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Identification and analysis of defective S288C genes
The CDSs obtained by consensus calling in each strain
were systematically evaluated in order to obtain informa-
tion about the presence of possible detrimental mutations
that can affect the functionality of encoded proteins. In
particular, we considered as highly detrimental both the
presence of an out-of-frame indel as well as the presence
of premature stop codons. CDS presenting such condi-
tions were defined as ‘defective’. Recovered CDSs (see
details in paragraph “Identification and analysis of S288C
introgressions”) were removed from the lists of defective
CDSs. The list of remaining defective genes was further
analysed as a present/absent binary matrix (Supporting
Information Table 5) involving all strains and S288C
genes. Complete hierarchical clustering on the binary
matrix was performed using the hclust function of the R
statistical package on a Jaccard’s Index-based distance
matrix from the R package Vegan (Dixon, 2003). To
graphically represent the distribution of defective genes
along the chromosomes, such genes were counted along
each chromosome (in window sized 5000 bp) for strains
grouped according to their clustering. Functional enrich-
ment was carried out with YeastMine (Balakrishnan
et al., 2012) on lists of CDSs, not including TY elements
and subtelomeric CDSs, characteristics for either clusters
or isolation sources. Enrichment significance was tested
by means of the hypergeometric test and the resulting p-
value corrected through the Holm–Bonferroni approach,
with significantly enriched Gene Ontology terms identified
as having an adjusted p-value<0.05.
Analysis of polymorphism frequency in CDS
The polymorphism frequency of each CDS was calcu-
lated for each whole-genome sequenced strain from
strain specific vcf files (see previous paragraphs) as the
ratio of the number of SNPs in a gene and its bp length
(as in the S288c reference, Supporting Information
Table 2). The relative polymorphism frequency (RPF)
estimator was designed as a functional score correlated
with the probability of maintaining the original function of
the CDS: the higher the score, the lower the possibility
that the gene function is maintained, finally mimicking
CDS deletion and affecting the relative pathway. The
complete matrix of polymorphism frequencies was inves-
tigated by complete hierarchical clustering using chord
distance as a distance metric.
Phenotyping and immunophenotyping of S. cerevisiae
strains
Each strain isolated in this study was characterized for
the following phenotypes: invasiveness, pseudohyphal
formation, growth at supra optimal temperatures, sporula-
tion rate and pH impact on growth, all performed as previ-
ously reported (Strati et al., 2016b). Growth was
qualitatively scored, sporulation efficiency was calculated
as the number of tetrads on the total of counted cells. Dif-
ferences among the qualitative phenotypes of strains
grouped according to either the genetic cluster or the iso-
lation source (intestinal or nonintestinal) were evaluated
through Chi-squared test of independence by using the
chisq.test() function of the MASS R package (Venables
and Ripley, 2002). Differences among quantitative phe-
notypes were evaluated through Mann–Whitney U test.
Additionally, cell wall sugar composition was assessed
through cell wall extraction and sugar quantification (glu-
cose for glucan content determination, mannose and glu-
cosamine for chitin content) by using high-performance
anion-exchange chromatography coupled with pulsed
electrochemical detection (HPAEC-PAD), as previously
described (Cavalieri et al., 2018). Aiming at the charac-
terization of the immune response elicited by the human
gut isolates, peripheral blood mononuclear cells (PBMCs)
were challenged with S. cerevisiae cells. PBMCs were
isolated from buffy coat obtained from 6 healthy donors
(age > 18 years old) according to the protocol approved
by the Ethical Committee of the Azienda Ospedaliera
Universitaria Careggi, Florence, Italy (Ref. n. 87/10). Writ-
ten informed consent was obtained for all the blood
donors. Blood separation, cell culture and stimulation
were performed as previously described (Cavalieri et al.,
2018). Challenges were carried out by culturing PBMCs
(105 cells/ml) with or without (negative control) live yeasts
(106 cells/ml) in RPMI 1640 medium supplemented with
10% heat-inactivated foetal bovine serum, 2 mM L-gluta-
mine, at 37 C under 5% CO2. At the time indicated
below, supernatants were collected and stored at −20 C
until assayed. Cytokine detection was performed using
the Human Milliplex® assay (Merck-Millipore) according
to the manufacturer’s instructions using Luminex technol-
ogy. TNF-α, IL-1β and IL-6, were detected in 24 h super-
natants; IFN-γ, IL-10, IL-13 and IL-17A in 5 days
supernatants.
RME1 gene sequencing and analysis
For each strain isolated in this study, the RME1 gene
and 599 nucleotides upstream the corresponding start
codon were sequenced through Sanger sequencing
using the RME1_FWseq and RME1_RVseq primers
listed in Supporting Information Table S7. As a reference,
other sequences of this gene were obtained from the
NCBI database or by extracting the region of interest
from genomic sequences downloaded from public data-
bases as described in previous paragraphs. Sequences
were aligned using clustalW and the SNP sequences
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were used to calculate the Kimura-2 parameters dis-
tances used to generate the neighbour-joining tree.
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